10X Infringes Bio-Rad Patents, Federal Circuit Affirms
The Federal Circuit on Friday upheld the U.S. International Trade Commission's finding that 10X Genomics infringed Bio-Rad Laboratories' patents on microfluidic chips used for genetic sequencing, rejecting 10X's argument that the...To view the full article, register now.
Already a subscriber? Click here to view full article